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Abstract
Background: The involvement of service users in health care provision in general, and specifically in substance use
disorder treatment, is of growing importance. This paper explores the views of patients in a therapeutic community
for alcohol dependence about clinical assessment, including general aspects about the evaluation process, and the
specific characteristics of four measures: two individualised and two standardised.
Methods: A focus group was conducted and data were analysed using a framework synthesis approach.
Results: Service users welcomed the experience of clinical assessment, particularly when conducted by therapists.
The duration of the evaluation process was seen as satisfactory and most of its contents were regarded as relevant
for their population. Regarding the evaluation measures, patients diverged in their preferences for delivery formats
(self-report vs. interview). Service users enjoyed the freedom given by individualised measures to discuss
topics of their own choosing. However, they felt that part of the standardised questions were difficult to
answer, inadequate (e.g. quantification of health status in 0–20 points) and sensitive (e.g. suicide-related
issues), particularly for pre-treatment assessments.
Conclusions: Patients perceived clinical assessment as helpful for their therapeutic journey, including the
opportunity to reflect about their problems, either related or unrelated to alcohol use. Our study suggests
that patients prefer to have evaluation protocols administered by therapists, and that measures should ideally
be flexible in their formats to accommodate for patient preferences and needs during the evaluation.
Keywords: User involvement, Clinical assessment, Personalised assessment, Evaluation measures, Patient views,
Individualised measures, Qualitative research
Background
Most mental health literature is based on a profes-
sional perspective, generated by researchers or practi-
tioners [1]. However, service users have expertise by
experience, which is why their involvement is increas-
ingly acknowledged as a crucial part of the health
care agenda [2–5].
One area where service user involvement is paramount
is the selection of measures to evaluate the patient’s clin-
ical condition [6–8]. Evaluation measures are helpful for
clinical work at different points in time during treatment.
At treatment intake, they allow the assessment of patients’
distress, and if administered at pre-post treatment, they
provide data for outcome assessment purposes. Several
authors have suggested that, to maximize their clinical
utility, these measures should be relevant, acceptable and
valuable for both professionals and service users [6, 9].
The reality, though, is that many popularly used measures
do not reflect the service users’ perspective [10–12].
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Consequently, we have little information on whether
the existing evaluation tools are meaningful, personally
relevant, and expressed in terms which make sense to
users [6, 8, 13].
User involvement in health care is even more challen-
ging among socially excluded and stigmatised groups,
since their views tend to be discredited, undermined and
regarded as unworthy [14–17]. This often applies to
patients in substance use disorder treatment services,
who seldom participate actively in shared decision-making
activities [14, 18, 19].
Just as with patients in general, patients in substance
use disorder treatment services have firsthand knowledge
about their clinical condition and are in a privileged
position to inform providers about which outcomes of
interest best reflect their reality [14, 20]. According to the
European Monitoring Centre for Drugs and Drug Addic-
tion, there are currently over 50 tools to measure treat-
ment outcomes in this population. The vast majority of
these are standardised, and do not take the patients’
perspective into account. A recent study gathered 76
variables commonly used by professionals to evaluate
recovery from substance use disorder, and service users
were asked their views about those criteria [20]. Patients
reported that some variables were unrealistic and hard to
achieve (e.g. to be completely anxiety-free). This study also
highlighted the frustration expressed by patients that most
existing variables did not capture individual idiosyncrasies
and personal preferences, stating that service providers
“had no idea of their experiences” (p. 31).
There has been a recent call for the use of individua-
lised data in the evaluation of substance use disorder
treatment [18, 21, 22]. Such data can be collected with
individualised measures, which are tailor-made lists of
items (problems or goals), generated in patients’ own
words [23]. Similarly to pre-set standardised measures,
these individualised items are rated for intensity in
quantitative scales (e.g. Likert scales). This allows an
evaluation of patients’ level of distress, based on their
unique problems.
Our study seeks to address three main concerns in this
field. First, there are a growing number of studies ex-
ploring what users of mental health services think about
clinical assessment, including views about the measures
and the process by which they are administered [24].
With the exception of the study by Neale and colleagues
[20], little is known about what patients in substance use
disorder treatment think about clinical assessment. Sec-
ond, a pioneer study published by Duong et al. [25] has
compared patients’ perspectives about standardised and
individualised measures in school mental health. To the
best of our knowledge, there are no reports on the use
of individualised measures in the field of substance use
disorder treatment, nor do we know how this population
perceives such measures. Third, the literature has sug-
gested that the majority of measures and patient-focused
materials in substance use disorder treatment tend to
require literacy skills above the average level of literacy
among this population [26, 27]. However, those who are
most likely to have low reading / writing skills (e.g. low
socio-economic status, limited education, marginalised
populations, and rural settings) are seldom asked to con-
tribute with their views on clinical assessment.
We were interested in understanding what patients in
substance use disorder treatment services, with low liter-
acy skills, think about clinical assessment, in general,
and in particular about standardised and individualised
measures. More specifically, our aims for this study were
two-fold: to explore patients’ overall perspectives about
their experience with the evaluation process; and to
investigate patients’ views about what is helpful and
hindering about each of the four measures in the evalu-
ation protocol. Ultimately, our goal was to understand
what makes patients engage, feel (de)motivated or (un)-
comfortable whilst using evaluation measures as part of
their treatment.
Methods
A single focus group with 10 service users was conducted
in a therapeutic inpatient community for females with
alcohol dependence, based in a rural area of northern
Portugal. This service targets women with severe alcohol
dependence problems, who are referred to this facility by
local drug and alcohol outpatient units, child protection
and social security services and general practitioners. The
treatment programme in this facility lasts approximately
for 8 months.
On sample characteristics, service users had a mean
age of 45 years (SD = 7). Six had completed primary
school,1 whilst the remaining four were illiterate. The
majority were unemployed (six participants) and nearly
all (eight participants) had a previous history of sub-
stance use treatment episodes. The group took place in
the community and was moderated by the first author
(PA), assisted by the community’s therapist. Ethical
approval was granted by the community’s clinical dir-
ector. As explained earlier, we opted for a sample with
these characteristics (i.e. severe addiction problems, dis-
advantaged socio-economic status, low literacy skills)
since this is likely to represent patients with greater
difficulties understanding evaluation measures.
The evaluation protocol used in the therapeutic commu-
nity consisted of four measures. Two were standardised
measures, namely, Treatment Outcomes Profile (TOP;
[28]) and Clinical Outcome Routine Evaluation – Outcome
Measure (CORE-OM; [29]); and two were individualised,
Psychological Outcome Profiles (PSYCHLOPS, [30]) and
Personal Questionnaire (PQ; [31]) (see Table 1 for more
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information). These measures were chosen for being widely
used in an international context.
The focus group was conducted in December 2013
and lasted for 2.5-3 h. Eight participants completed the
measures at treatment intake only (between Oct-Nov
2013). The remaining two completed the measures twice
i.e. at treatment intake (June 2013) and 7 months after
(December 2013).
The group discussion was guided by a semi-structured
interview focusing on patients’ views about: 1) the
evaluation process, i.e. overall satisfaction, duration in
time, administration and adequacy of contents of the
evaluation protocol; and 2) the helpful and hindering
characteristics of each measure in the evaluation proto-
col i.e. questionnaire length, delivery format and topics
covered by the items.
The session was audio-recorded and transcribed ver-
batim. The transcripts were analysed following a frame-
work synthesis approach [32], based on categories,
created a priori, that reflected the information which we
aimed to extract (i.e. general aspects about the evalu-
ation process and helpful and hindering aspects of each
measure). Data extraction and synthesis was made by
one of us (PA) and later discussed with two senior
academics (CS and a senior lecturer in Philosophy with
expertise in health ethics).
Results
General views about the evaluation process
The evaluation process was reported by most service
users as a positive experience, because it helped them to
reflect about their clinical situation. The overall duration
of the evaluation protocol was considered as adequate
(“The bigger it is, the more we discover things that we
did not know about ourselves”, P72). Patients found it
helpful to have their own therapist administering the
measures, since “these things are very intimate… if it
wasn’t our therapist, we wouldn’t have cared” (P4).
Among those that completed the questionnaires
twice, patients felt that certain topics had been difficult
to address at treatment intake (“The questions are not
wrong, but we’re not used to being honest with our-
selves, I was still sort of numb”, P9). However, when
answering later in treatment, another patient reported
that the questionnaires made her aware of how much
she had changed since starting the therapeutic commu-
nity programme (“It made me think about how differ-
ent I am. When I arrived I was at the bottom and now
I am a new woman”, P7). Patients also considered that
all evaluations performed after treatment intake should
have been focused on other aspects besides their per-
sonal problems, particularly their progress in treatment
and the changes that they perceive (“We were given the
chance to talk about the problems that we still had, but
we could also talk about how we were recovering (…)
and I have come such a long way”, P7).
Helpful and hindering aspects of the evaluation measures
Nearly all measures in the protocol were deemed as ad-
equate in their length, except for CORE-OM, which was
considered as “too big” (P4). There was some variability
regarding the preferred delivery format, with some patients
finding the self-report structure to be more appealing, as “it
was easier to tick boxes… we don’t have to think so hard
about our problems” (P9) and that “we can be more honest
by using a pen” (P3); and others reporting that “if we are
forced to talk, it is better because we end up saying some-
thing” (P7). Regarding the topics covered by the items,
particularly among the standardised measures, there were
certain questions that patients found impropriate and hard
to answer. Table 2 summarizes the helpful and hindering
aspects of each measure as identified by patients.
Table 1 Summary of measures used in the research protocol
Type of
measure
Measure Generation of
items/problems
Domains
covered
Nr. items Size
(A4 pages)
Type of
items
Delivery
format
Example
of item
Standardised TOP Researchers/
professionals
Drug and alcohol use,
injecting risk behaviours,
offending and
criminal involvement,
health and social
functioning
21 1 Yes/no,
Sliding
scales
Interview Q3a: “Committed
assault or violence”
CORE-OM Researchers/
professionals
Subjective well-being,
symptoms, functioning, risk
34 2 Likert
scale
Self-report Q2: “I have felt
tense, nervous
or anxious”
Individualised PSYCHLOPS Patients Any of patient’s own
choosing
4 1 Likert
scale
Self-report Q1 response:
“People in my
neighborhood
disrespect me”
PQ Patients Any of patient’s own
choosing
Unlimited 2 Likert
scale
Interview PQ response:
“I miss my family”
a“Q”, followed by a number (“Q1”) refers to the number of the item in the questionnaire.
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Table 2 Helpful and hindering aspects of TOP, CORE-OM, PSYCHLOPS and PQ as reported by patients
Helpful Hindering
Key aspects Patients’ voices Key aspects Patients’ voices
TOP Raises awareness about the quantity
of drugs/alcohol used
Promotes emotional/breakthrough
experiences
“It is a way of getting yourself
together, we have no idea about
how much alcohol we used to
drink and the money we spent”, P3
0–20 scale questions to rate psychological/
physical health and quality of life difficult to
understand and meaningless
“When I was asked about this I answered
by chance. It meant nothing to me. Later
we are able to answer in another way”, P5
CORE-OM User-friendly
Contents relevant to this population
Enhances self-awareness
“This instrument is related to what
we are”, P7
Large number of items
Contains questions about sensitive topics
(e.g. suicide) Items not generated by patients
“The questions were made by other
people and the words didn’t come from
inside of us”, P7
PSYCHLOPS Easy to understand
Helps reflecting about personal difficulties
Provides freedom of expression to talk
about any topic, related or not
to substance use
Makes patients feel like “normal” people
“It not just about the alcohol, we
feel bad about many other things
in life. My sister doesn’t drink
alcohol but could answer this too,
because everyone has problems”, P8
Requires personal exposure
The self-completion format may lead to
misleading or incomplete answers
“We want to hide our real problems for
fears of being judged (…) if the words are
already written by someone else, it is easier
to just say yes or no”, P7
PQ Opportunity for self-reflection
Oral format encourages to talk
about personal problems
“When a person encourages us to
talk, we become more comfortable
and open. I talked about my drinking
problem...” P7
Patients reported none. “It is fine as it is”, P1
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Discussion
The purpose of this study was to explore the thoughts of
a sample of patients in substance use disorder treatment
about the process of clinical assessment. It also aimed to
hear those patients’ voices about the characteristics of
four evaluation measures that all of them used at treat-
ment intake, and some also later in treatment. Among
these were two individualised measures, in addition to
two traditional and widely used standardised measures.
Our first goal was to investigate patients’ general views
about the evaluation process and the findings were
encouraging. We learned that patients not only wel-
comed clinical assessment, but also perceived it as a
valuable task for their therapeutic journey. Patients were
satisfied with the duration of the evaluation protocol
(which included six A4 size pages) and there was even
openness for the inclusion of further items. Previous
studies [6, 7] have shown that patients tend to be
concerned about the brevity of several measures, for be-
ing “too simplistic”. In contrast, studies of services and
therapists, report that evaluation measures can become
a burden for patients and potentially interfere with the
time assigned for the consultations and treatment [33].
There was a general preference to have therapists
administering the evaluation protocol, making it a mean-
ingful part of the therapeutic process and potentially
leading to a greater commitment with the task. As such,
we believe that clinical assessment could be formally
included as part of treatment, which has already been
proposed by authors such as Valderas [34]. The major
advantage of this is that using evaluation measures
would not require extra human and time resources from
the service, making it a potentially more feasible task in
real clinical settings. As a downside, one must bear in
mind that when therapists administer the protocol dir-
ectly, patients’ answers are likely to be biased, particu-
larly in oral interviews. In such cases, patients may feel
the need to provide desirable answers and underreport
undesirable behaviours, to satisfy their therapist, as
reported by Bowling [35]. However, unless patients are
under court-ordered treatment, they tend to be disposed
and motivated to disclose personal and clinically relevant
information to their therapists. Hence, we believe that if
the interviewer is also the therapist, the risk of offering
socially desirable answers is likely to decrease. Consider-
ing that most research about social desirability in mental
health has been conducted with non-clinical samples
[35] further studies are needed to ascertain the pros and
cons of having therapists as interviewers in clinical
assessment, which is something that, as we have seen,
patients seem to prefer.
Our second main goal was to learn what was helpful and
hindering about the measures in the evaluation protocol,
from the patient perspective. There was a tension regarding
service users’ preferences about the delivery format of
measures, with some favouring the simplicity of tick-
ing boxes, and others keener on talking about their
problems. This suggests that a one-size-fits-all ap-
proach to evaluation is not enough and flexibility is
desirable, so that patients’ preferences can be consid-
ered. Such flexibility has already been suggested by
Gordon and colleagues [24]. As such, we need to fur-
ther explore to what extent the psychometric proper-
ties of an instrument remain unaltered in multiple
formats of application, i.e. allowing a flexible adminis-
tration of measures while providing reliable informa-
tion for treatment evaluation.
However, when it came to eliciting personalised in-
formation, most patients in our group preferred the dia-
logue, oral format of PQ, rather than describing their
problems in writing, as required by the PSYCHLOPS
questionnaire. This is consistent with the study by
Ashworth and colleagues [36], where therapists felt that
PSYCHLOPS was challenging because patients not only
had to identify problems on their own, but also to use
their own words to write their problems down.
In our study, standardised and individualised measures
were seen as relevant for clinical assessment, despite
having certain disadvantages. TOP and CORE-OM were
perceived as useful and relevant for this population,
suggesting a good level of acceptability among patients.
Nevertheless, not all contents covered by these two
standardised measures were regarded as meaningful or
appropriate (e.g. rating psychological health in a 20-point
scale). Also, service users expressed some reservations
about the disclosure of sensitive personal information in
certain TOP and CORE-OM items, as shown in other
studies [37]. One likely consequence of patients feeling
uncomfortable or dissatisfied with the evaluation ques-
tionnaires is the likelihood of misleading and/or missing
responses. Thus, further research is needed to ascertain
which topics are likely to trigger negative reactions to the
evaluation process.
As expected, patients appreciated the freedom given
by both individualised measures, PSYCHLOPS and PQ,
to express any type of personal concern, regardless of
topic. This was in line with Duong and colleagues [25],
who demonstrated that recipients of mental health care
consider individualised measures to be less confining than
their standardised counterparts. Hence, our findings indi-
cate that accommodating a great diversity of topics is
important to patients, since misusing substances can lead
to/or be the consequence of problems that drug-focused
instruments might not address. Future research should
compare the topics elicited from standardised and indivi-
dualised measures, so that we understand if the former
tend to overlook aspects of relevance for patients that the
latter are able to capture.
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Finally, it is also worth emphasizing that patients who
responded to the evaluation measures at treatment
intake and later in treatment valued the opportunity to
focus on other aspects besides outcomes. This could be
overcome by including items about the treatment
process, giving patients the opportunity to share their
thoughts about the care they are receiving. Such feed-
back about treatment could be used by clinicians to
adjust the intervention to match the patient’s needs, as
well as to increase therapeutic alliance [38].
This study is not without limitations. To have a female
only, small sample size means that the findings are less
generalisable and conclusions should be interpreted with
caution. Also, the presence of the patients’ therapist in the
group may have overstated their positive views about the
evaluation process and the measures included in our study.
Conclusions
This study suggests that service users can actively contrib-
ute to improving the process of clinical assessment, guid-
ing researchers and professionals towards developing
evaluation measures that are more meaningful and rele-
vant for patients with alcohol dependency. Individualised
outcome measures have the potential to broaden the
range of viewpoints captured from patients compared to
the more narrowly focused standardised instruments.
Endnotes
1In Portugal, the term “primary school” refers to 4 years
of education, from the age of 6 to 10, and is also known as
the 1st cycle of basic education.
2“P”, followed by a number (e.g. “P3”) is an anonymous
designator for each focus group participant.
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treatment outcomes profile
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